TipRanks
KUKJE PHARMA Co., Ltd. (KR:002720)
:002720
South Korea Market
002720
KUKJE PHARMA Co., Ltd.
RESEARCH TOOLSreports

KUKJE PHARMA Co., Ltd. (002720) Financial Statements

― Followers

KUKJE PHARMA Co., Ltd. Financial Overview

KUKJE PHARMA Co., Ltd.'s market cap is currently ₩66.48B. The company's EPS TTM is ₩239.89; its P/E ratio is 13.71; and it has a dividend yield of 0.91%. KUKJE PHARMA Co., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 175.50B₩ 156.46B₩ 135.37B₩ 126.58B₩ 119.75B
Gross Profit₩ 92.97B₩ 82.50B₩ 67.22B₩ 63.25B₩ 54.47B
Operating Income₩ 6.18B₩ 6.70B₩ -1.99B₩ 5.27B₩ -401.29M
EBITDA₩ 9.41B₩ 11.02B₩ -1.04B₩ 10.23B₩ 4.08B
Net Income₩ 5.70B₩ 5.21B₩ -8.42B₩ 3.56B₩ -1.56B
Balance Sheet
Cash & Short-Term Investments₩ 10.72B₩ 8.75B₩ 10.63B₩ 5.56B₩ 7.90B
Total Assets₩ 190.53B₩ 165.55B₩ 163.26B₩ 136.59B₩ 139.78B
Total Debt₩ 30.40B₩ 29.51B₩ 30.66B₩ 28.60B₩ 35.99B
Net Debt₩ 19.70B₩ 20.83B₩ 20.07B₩ 23.06B₩ 28.12B
Total Liabilities₩ 92.83B₩ 76.00B₩ 78.31B₩ 62.51B₩ 71.20B
Stockholders' Equity₩ 97.69B₩ 89.54B₩ 84.94B₩ 74.07B₩ 68.57B
Cash Flow
Free Cash Flow₩ 2.22B₩ 945.21M₩ 2.53B₩ 5.23B₩ 7.64B
Operating Cash Flow₩ 5.84B₩ 3.94B₩ 3.58B₩ 6.50B₩ 9.60B
Investing Cash Flow₩ -4.16B₩ -4.76B₩ -1.18B₩ -1.35B₩ -3.38B
Financing Cash Flow₩ 343.87M₩ -1.20B₩ 2.61B₩ -7.47B₩ -2.43B
Currency in KRW

KUKJE PHARMA Co., Ltd. Earnings and Revenue History

Income Statement >

KUKJE PHARMA Co., Ltd. Debt to Assets

Balance Sheet >

KUKJE PHARMA Co., Ltd. Cash Flow

Cash Flow >

KUKJE PHARMA Co., Ltd. Forecast EPS vs Actual EPS

Earnings >